TABLE 2.
PEDro assessment quality results of included studies.
References | Eligibility* | Random allocation | Concealed allocation | Baseline comparability | Blind subjects | Blind therapists | Blind assessors | Adequate follow-up | Intention-to-treat analysis | Between-group comparisons | Point estimates and variability | Total score (0–10) | Quality |
Barra et al. (2022) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | Excellent |
Cavinato et al. (2019) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | Excellent |
Chen et al. (2021) | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | Good |
Chi et al. (2018) | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | Good |
Estraneo et al. (2017) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8 | Good |
Guo et al. (2021) | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | Good |
Huang et al. (2017) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | Excellent |
Li et al. (2021) | YES | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 | Good |
Martens et al. (2018) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 8 | Good |
Martens et al. (2019) | Yes | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 | Good |
Martens et al. (2020) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | Excellent |
Thibaut et al. (2014) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | Excellent |
Thibaut et al. (2017) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 8 | Good |
Thibaut et al. (2019a) | Yes | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | Excellent |
Wu et al. (2019) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
Zhang et al. (2017) | Yes | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 8 | Good |
Zhang et al. (2020) | Yes | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 8 | Good |
*Eligibility criteria is not included in the scoring of PEDro scale.